These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 38240118)

  • 1. Senolytic combination of dasatinib and quercetin protects against diabetic kidney disease by activating autophagy to alleviate podocyte dedifferentiation via the Notch pathway.
    Zhu X; Zhang C; Liu L; Xu L; Yao L
    Int J Mol Med; 2024 Mar; 53(3):. PubMed ID: 38240118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Senolytic combination of dasatinib and quercetin attenuates renal damage in diabetic kidney disease.
    Guo X; Wen S; Wang J; Zeng X; Yu H; Chen Y; Zhu X; Xu L
    Phytomedicine; 2024 Jul; 130():155705. PubMed ID: 38761776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Krüppel‑like factor 4 ameliorates diabetic kidney disease by activating autophagy via the mTOR pathway.
    Gong J; Zhan H; Li Y; Zhang W; Jin J; He Q
    Mol Med Rep; 2019 Oct; 20(4):3240-3248. PubMed ID: 31432191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p66Shc regulates podocyte autophagy in high glucose environment through the Notch-PTEN-PI3K/Akt/mTOR pathway.
    Zheng D; Tao M; Liang X; Li Y; Jin J; He Q
    Histol Histopathol; 2020 Apr; 35(4):405-415. PubMed ID: 31650524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Qizhi Jiangtang capsule activates podocyte autophagy in diabetic kidney disease by inhibiting phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin pathways.
    Zhaoan G; Lina S; Yingying L; Ruifeng LI; Chong L; Ke D; Jing S; Jun S
    J Tradit Chin Med; 2023 Aug; 43(4):667-675. PubMed ID: 37454251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tripterygium glycoside protects diabetic kidney disease mouse serum-induced podocyte injury by upregulating autophagy and downregulating β-arrestin-1.
    Zhan H; Jin J; Liang S; Zhao L; Gong J; He Q
    Histol Histopathol; 2019 Aug; 34(8):943-952. PubMed ID: 30839094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Podocyte Injury in Diabetic Kidney Disease in Mouse Models Involves TRPC6-mediated Calpain Activation Impairing Autophagy.
    Salemkour Y; Yildiz D; Dionet L; 't Hart DC; Verheijden KAT; Saito R; Mahtal N; Delbet JD; Letavernier E; Rabant M; Karras A; van der Vlag J; Nijenhuis T; Tharaux PL; Lenoir O
    J Am Soc Nephrol; 2023 Nov; 34(11):1823-1842. PubMed ID: 37678257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D Ameliorates Podocyte Injury by Enhancing Autophagy Activity in Diabetic Kidney Disease.
    Zhang X; Zhang L; Wen Y; Zhang M; Liu S; Xiao H
    Kidney Blood Press Res; 2023; 48(1):314-325. PubMed ID: 37054686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tripterygium glycoside suppresses epithelial‑to‑mesenchymal transition of diabetic kidney disease podocytes by targeting autophagy through the mTOR/Twist1 pathway.
    Tao M; Zheng D; Liang X; Wu D; Hu K; Jin J; He Q
    Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34165172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JAK/STAT pathway promotes the progression of diabetic kidney disease via autophagy in podocytes.
    Chen D; Liu Y; Chen J; Lin H; Guo H; Wu Y; Xu Y; Zhou Y; Zhou W; Lu R; Zhou J; Wu J
    Eur J Pharmacol; 2021 Jul; 902():174121. PubMed ID: 33901462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PFKP Activation Ameliorates Foot Process Fusion in Podocytes in Diabetic Kidney Disease.
    Zhang Z; Liang W; Luo Q; Hu H; Yang K; Hu J; Chen Z; Zhu J; Feng J; Zhu Z; Chi Q; Ding G
    Front Endocrinol (Lausanne); 2021; 12():797025. PubMed ID: 35095764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placenta-derived mesenchymal stem cells protect against diabetic kidney disease by upregulating autophagy-mediated SIRT1/FOXO1 pathway.
    Liu H; Wang J; Yue G; Xu J
    Ren Fail; 2024 Dec; 46(1):2303396. PubMed ID: 38234193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Podocyte EGFR Inhibits Autophagy Through Upregulation of Rubicon in Type 2 Diabetic Nephropathy.
    Li Y; Pan Y; Cao S; Sasaki K; Wang Y; Niu A; Fan X; Wang S; Zhang MZ; Harris RC
    Diabetes; 2021 Feb; 70(2):562-576. PubMed ID: 33239448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of Risa improves podocyte injury by enhancing autophagy in diabetic nephropathy.
    Su PP; Liu DW; Zhou SJ; Chen H; Wu XM; Liu ZS
    Mil Med Res; 2022 May; 9(1):23. PubMed ID: 35614465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosome secreted from adipose-derived stem cells attenuates diabetic nephropathy by promoting autophagy flux and inhibiting apoptosis in podocyte.
    Jin J; Shi Y; Gong J; Zhao L; Li Y; He Q; Huang H
    Stem Cell Res Ther; 2019 Mar; 10(1):95. PubMed ID: 30876481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced glycation end-products suppress autophagic flux in podocytes by activating mammalian target of rapamycin and inhibiting nuclear translocation of transcription factor EB.
    Zhao X; Chen Y; Tan X; Zhang L; Zhang H; Li Z; Liu S; Li R; Lin T; Liao R; Zhang Q; Dong W; Shi W; Liang X
    J Pathol; 2018 Jun; 245(2):235-248. PubMed ID: 29570219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tangshen formula protects against podocyte apoptosis via enhancing the TFEB-mediated autophagy-lysosome pathway in diabetic nephropathy.
    Wang Y; Peng L; Lu X; Zhang H; Zhao H; Zhao T; Yang L; Mao H; Ma F; Liu T; Li P; Zhan Y
    J Ethnopharmacol; 2024 Apr; 324():117721. PubMed ID: 38199335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wogonin protects glomerular podocytes by targeting Bcl-2-mediated autophagy and apoptosis in diabetic kidney disease.
    Liu XQ; Jiang L; Li YY; Huang YB; Hu XR; Zhu W; Wang X; Wu YG; Meng XM; Qi XM
    Acta Pharmacol Sin; 2022 Jan; 43(1):96-110. PubMed ID: 34253875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapamycin promotes podocyte autophagy and ameliorates renal injury in diabetic mice.
    Xiao T; Guan X; Nie L; Wang S; Sun L; He T; Huang Y; Zhang J; Yang K; Wang J; Zhao J
    Mol Cell Biochem; 2014 Sep; 394(1-2):145-54. PubMed ID: 24850187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease.
    Hickson LJ; Langhi Prata LGP; Bobart SA; Evans TK; Giorgadze N; Hashmi SK; Herrmann SM; Jensen MD; Jia Q; Jordan KL; Kellogg TA; Khosla S; Koerber DM; Lagnado AB; Lawson DK; LeBrasseur NK; Lerman LO; McDonald KM; McKenzie TJ; Passos JF; Pignolo RJ; Pirtskhalava T; Saadiq IM; Schaefer KK; Textor SC; Victorelli SG; Volkman TL; Xue A; Wentworth MA; Wissler Gerdes EO; Zhu Y; Tchkonia T; Kirkland JL
    EBioMedicine; 2019 Sep; 47():446-456. PubMed ID: 31542391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.